Article
Oncolytic virus treatment differentially affects the CD56 <sup>dim</sup> and CD56 <sup>bright</sup> NK cell subsets <i>in vivo</i> and regulates a spectrum of human NK cell activity
2020-12-16
Abstract excerpt
Natural killer (NK) cells protect against intracellular infection and cancer. These properties are exploited in oncolytic virus (OV) therapy, where anti-viral responses enhance anti-tumour immunity. We have analysed the mechanism by which reovirus, an oncolytic dsRNA virus, modulates human NK cell activity. Reovirus activates NK cells in a type I interferon (IFN-I) dependent manner, resulting in STAT1 and STAT4 si...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 95181b03-2433-56a0-a5ea-b181cdd20350
- DOI
- 10.1101/2020.12.16.423062
